BioCision

Larkspur, United States Founded: 2007 • Age: 19 yrs
Provider of handling, storage and transport solutions for temperature-sensitive biomedical samples and drugs
Annual revenue - Latest available
Total funding $11.1M 4 rounds
Employees 48 Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About BioCision

BioCision is a company based in Larkspur (United States) founded in 2007. BioCision has raised $11.1 million across 4 funding rounds from investors including Brooks Automation, CYWP Fund and Research Corporation Technologies. The company has 48 employees as of December 31, 2022. BioCision operates in a competitive market with competitors including Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.

  • Headquarter Larkspur, United States
  • Employees 48 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Biocision Llc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $11.1 M (USD)

    in 4 rounds

  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    48

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of BioCision

Headcount 1000-5000
Employee Profiles 257
Board Members and Advisors 7
Employee Profiles
People
Steven Wernke
Finance Manager
People
Aline Bronzato-Badial
Assistant Manager
People
Dylan Carson
Senior Associate Scientist - Clinical
People
Matthew Colucci
Account Manager - Multiomics & Synthesis Solutions

Unlock access to complete

Board Members and Advisors
people
Robyn C. Davis
Director
people
Frank E. Casal
Director
people
Ellen M. Zane
Director
people
Mark S. Wrighton
Director

Unlock access to complete

Funding Insights of BioCision

BioCision has successfully raised a total of $11.1M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in BioCision

BioCision has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Brooks Automation, CYWP Fund and Research Corporation Technologies.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Flexible growth capital is provided by CYWP Fund.
Locked Locked Locked
Research Corporation Technologies is engaged in licensing biomedical technologies.
Locked Locked Locked
Vacuum robots for semiconductor wafer handling are developed.
Locked Locked Locked
Premium access

Investor details for BioCision

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BioCision

Investments
Premium access

Investment portfolio details for BioCision

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - BioCision

Premium access

Detailed financials for BioCision

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Biocision Comparisons

BioCision Primary company
Description
Provider of handling, storage and transport solutions for te...
Location
Larkspur, United States
Founded Year
2007
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
48
As of 2022
Premium access

Peer comparison for BioCision

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of BioCision

BioCision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Vacuum robots for semiconductor wafer handling are developed.
Locked Locked Locked
Cold storage solutions for organ transplant preservation are provided.
Locked Locked Locked
Technologies for blood and product storage are developed.
Locked Locked Locked
Technology for cell storage and transportation is developed.
Locked Locked Locked
Portable devices for cell storage and transport are provided.
Locked Locked Locked
Thermal packaging solutions and cold chain monitoring services are provided.
Premium access

Detailed competitors of BioCision

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Biocision

Premium access

Complete news archive for BioCision

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioCision

BioCision was founded in 2007 and raised its 1st funding round 6 years after it was founded.

BioCision is headquartered in Larkspur, United States. It is registered at Larkspur, Colorado, United States.

BioCision is a funded company, having raised a total of $11.1M across 4 funding rounds to date.

As of Dec 31, 2022, the latest employee count at BioCision is 48.

BioCision develops and supplies cell cryopreservation products, systems, and solutions. Products include CoolCell Freezing Containers, ThawSTAR Automated Cell Thawing Systems, BioT Temperature Stability Systems, CoolRack Tube Cooling Modules, CoolSink Plate Cooling Modules, ThermalTray Cooling Platforms, TruCool Hinged CryoBoxes, TruCool Leak-Proof Cryogenic Vials and TruCool Lab Accessories. Its products are used by institutions in the biotech, pharmaceutical, clinical, diagnostic, academic and government scientific community.

BioCision's top competitors include Brooks Automation, Hemanext and Bridge to Life.

BioCision has 3 investors. Key investors include Brooks Automation, CYWP Fund, and Research Corporation Technologies.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available